Pfizer (PFE) says it has filed new drug applications for Crizotinib, an oral cancer drug, with...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) says it has filed new drug applications for Crizotinib, an oral cancer drug, with both the FDA and its Japanese counterpart, and that the FDA has granted it priority review status. (PR)